| Oct 28 2020 |
CDC Broadens “Close Contact” Guidance – Employment Law This Week [VIDEO] |
Epstein Becker & Green, P.C. |
| Oct 28 2020 |
Time for a Checkup: Recent Federal Efforts Regarding Telehealth - Part I |
Ward and Smith, P.A. |
| Oct 28 2020 |
Therapy Clients Become Targets of Blackmail Campaign |
K&L Gates LLP |
| Oct 27 2020 |
I've Been Indicted on Healthcare Fraud Charges—Now What? |
Oberheiden P.C. |
| Oct 27 2020 |
Brexit and COVID-19: Changes to the Regulation of Medicines |
McDermott Will & Schulte LLP |
| Oct 27 2020 |
Caregiver Support During the COVID-19 Pandemic – A Conundrum for Employers |
Epstein Becker & Green, P.C. |
| Oct 27 2020 |
FBI: Scammers in Disguise Target Health Care Providers with Threats and Phony Investigations |
Steptoe & Johnson PLLC |
| Oct 26 2020 |
COVID-19: US State Policy Report – October 20-26, 2020 |
Squire Patton Boggs (US) LLP |
| Oct 26 2020 |
Surgical Masks, Respirators, and More: Employers Grapple with Personal Protective Equipment Requirements Amid Constantly Evolving COVID-19 Guidance and Laws |
Jackson Lewis P.C. |
| Oct 24 2020 |
Clarity on Reporting and Enforcement: CMS Issues Guidance Regarding Hospital COVID-19 Reporting Requirements |
Sheppard, Mullin, Richter & Hampton LLP |
| Oct 23 2020 |
COVID-19 Weekly Newsletter: U.S. Eyes Third Wave as Scientific Understanding, FDA Actions Advance |
Faegre Drinker |
| Oct 23 2020 |
CDC Expands the Definition of Close Contact for COVID-19 |
Dinsmore & Shohl LLP |
| Oct 23 2020 |
McDermottPlus Check-Up: October 23, 2020 |
McDermott Will & Schulte LLP |
| Oct 23 2020 |
New York State Releases First Guidance on New Paid Sick Leave Law |
Sheppard, Mullin, Richter & Hampton LLP |
| Oct 23 2020 |
K&L Gates Triage: CMS Cease and Desist Letters to COVID Labs and Reimbursement Dispute |
K&L Gates LLP |
| Oct 23 2020 |
HHS Pirouettes Back to Original Position that Provider Relief Fund Payments May be Used to Replace Gross Revenue, Not Just Profits, Lost Due to the Coronavirus |
Squire Patton Boggs (US) LLP |
| Oct 23 2020 |
OCR Settles with NY Spine for Failure to Provide Access to Records |
Robinson & Cole LLP |
| Oct 23 2020 |
CPSC Issues COVID-19 Guidance on Personal Protective Equipment Intended for Consumers |
Hunton Andrews Kurth |
| Oct 23 2020 |
New York State Addresses Paid Sick Leave Requirements in New Guidance |
Mintz |
| Oct 23 2020 |
When Governors Bite Back: Circuit Court Upholds Hawaii Governor’s Emergency Powers |
Proskauer Rose LLP |
| Oct 23 2020 |
CDC Refines “Close Contact” Guidelines |
Ogletree, Deakins, Nash, Smoak & Stewart, P.C. |
| Oct 22 2020 |
CMS Proposes Expanded Options for Determining “Reasonable and Necessary” |
Polsinelli PC |
| Oct 22 2020 |
Value-Based Care Comes Full Circle: New CMS Guidance for Medicaid Programs |
Polsinelli PC |
| Oct 22 2020 |
Gaps in Payment for COVID-19 Laboratory Testing Plague Providers and Patients |
Polsinelli PC |
| Oct 22 2020 |
What Other Reimbursement Changes Occurred While I Was Focused on COVID-19? |
Polsinelli PC |
| Oct 22 2020 |
Close Encounters of the (Cumulative) 15 Minute Kind |
Jackson Lewis P.C. |
| Oct 22 2020 |
Implementation of Evaluation and Management (“E/M”) Service Payment Creates Uncertainty for Medicare Professional Services Payment and Policy |
Polsinelli PC |
| Oct 21 2020 |
What Legal Protections Exist for Employees who Use Medical Marijuana? |
Katz Banks Kumin LLP |
| Oct 21 2020 |
The Intersection of State Escheatment Laws and Patient Credit Balances: Preparing for Increased State Action in the Era of COVID-19 |
Polsinelli PC |
| Oct 21 2020 |
Future of the Affordable Care Act – Supreme Court Scenarios |
McDermott Will & Schulte LLP |
| Oct 21 2020 |
CDC Refines List of Underlying Conditions That Place Individuals at ‘Increased Risk of Severe Illness’ From COVID-19 |
Ogletree, Deakins, Nash, Smoak & Stewart, P.C. |
| Oct 21 2020 |
Catching Up on Recent Developments Surrounding CARES Act Stimulus Funds |
Polsinelli PC |
| Oct 21 2020 |
New York State Issues Guidance and FAQs for Paid Sick Leave Law |
Ogletree, Deakins, Nash, Smoak & Stewart, P.C. |
| Oct 21 2020 |
Drug Manufacturers Unlawfully Target 340B Program Reductions |
Polsinelli PC |
| Oct 21 2020 |
States Move to Make Permanent COVID-19 Telehealth Waivers |
Polsinelli PC |
